Victoria M. Richon
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Cancer-related gene regulation, Peptidase Inhibition and Analysis
Most-Cited Works
- → Histone deacetylases and cancer: causes and therapies(2001)1,852 cited
- → Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors(1999)1,685 cited
- → Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells(2000)1,162 cited
- → Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)(2006)1,133 cited
- → Histone deacetylase inhibitor selectively induces p21 WAF1 expression and gene-associated histone acetylation(2000)1,093 cited
- → Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor(2011)930 cited
- → A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases(1998)912 cited
- → Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer(2005)903 cited
- → MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L(2011)888 cited
- → Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease(2003)838 cited